EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:EXE - CA30224T8639 - Common Stock
20.55 CAD
-0.44 (-2.1%)
We assign a fundamental rating of 6 out of 10 to EXE. EXE was compared to 14 industry peers in the Health Care Providers & Services industry. EXE has an excellent profitability rating, but there are some minor concerns on its financial health. EXE has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year EXE was profitable.
In the past year EXE had a positive cash flow from operations.
In the past 5 years EXE has always been profitable.
EXE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
EXE has a Return On Assets of 10.41%. This is amongst the best in the industry. EXE outperforms 85.71% of its industry peers.
With an excellent Return On Equity value of 55.53%, EXE belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
EXE's Return On Invested Capital of 18.54% is amongst the best of the industry. EXE outperforms 100.00% of its industry peers.
EXE had an Average Return On Invested Capital over the past 3 years of 11.40%. This is above the industry average of 7.17%.
The last Return On Invested Capital (18.54%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROIC | 18.54% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
The Profit Margin of EXE (5.72%) is better than 85.71% of its industry peers.
In the last couple of years the Profit Margin of EXE has grown nicely.
EXE has a Operating Margin of 8.22%. This is in the better half of the industry: EXE outperforms 78.57% of its industry peers.
In the last couple of years the Operating Margin of EXE has grown nicely.
With a Gross Margin value of 14.15%, EXE is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of EXE has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
EXE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for EXE has been increased compared to 1 year ago.
The number of shares outstanding for EXE has been reduced compared to 5 years ago.
Compared to 1 year ago, EXE has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.18 indicates that EXE is not in any danger for bankruptcy at the moment.
EXE has a Altman-Z score of 3.18. This is amongst the best in the industry. EXE outperforms 85.71% of its industry peers.
The Debt to FCF ratio of EXE is 3.39, which is a good value as it means it would take EXE, 3.39 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.39, EXE is doing good in the industry, outperforming 78.57% of the companies in the same industry.
A Debt/Equity ratio of 1.94 is on the high side and indicates that EXE has dependencies on debt financing.
EXE has a Debt to Equity ratio of 1.94. This is in the lower half of the industry: EXE underperforms 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Altman-Z | 3.18 |
ROIC/WACC2.41
WACC7.68%
2.3 Liquidity
EXE has a Current Ratio of 0.81. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.81, EXE is in line with its industry, outperforming 57.14% of the companies in the same industry.
A Quick Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
EXE has a Quick ratio of 0.81. This is in the better half of the industry: EXE outperforms 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 52.52% over the past year.
The Earnings Per Share has been growing by 22.74% on average over the past years. This is a very strong growth
EXE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.59%.
EXE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.31% yearly.
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
3.2 Future
Based on estimates for the next years, EXE will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.75% on average per year.
Based on estimates for the next years, EXE will show a quite strong growth in Revenue. The Revenue will grow by 10.83% on average per year.
EPS Next Y23.8%
EPS Next 2Y10.47%
EPS Next 3Y5.59%
EPS Next 5Y9.75%
Revenue Next Year12.04%
Revenue Next 2Y9.4%
Revenue Next 3Y6.78%
Revenue Next 5Y10.83%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.76, EXE is valued on the expensive side.
Based on the Price/Earnings ratio, EXE is valued cheaper than 85.71% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.31, EXE is valued a bit cheaper.
With a Price/Forward Earnings ratio of 21.11, EXE is valued on the expensive side.
78.57% of the companies in the same industry are more expensive than EXE, based on the Price/Forward Earnings ratio.
EXE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.76 | ||
| Fwd PE | 21.11 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXE indicates a somewhat cheap valuation: EXE is cheaper than 78.57% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXE indicates a somewhat cheap valuation: EXE is cheaper than 64.29% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.28 | ||
| EV/EBITDA | 11.42 |
4.3 Compensation for Growth
EXE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of EXE may justify a higher PE ratio.
PEG (NY)0.83
PEG (5Y)0.87
EPS Next 2Y10.47%
EPS Next 3Y5.59%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 2.40%.
EXE's Dividend Yield is rather good when compared to the industry average which is at 3.28. EXE pays more dividend than 85.71% of the companies in the same industry.
EXE's Dividend Yield is comparable with the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.4% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
45.22% of the earnings are spent on dividend by EXE. This is a bit on the high side, but may be sustainable.
EXE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP45.22%
EPS Next 2Y10.47%
EPS Next 3Y5.59%
TSX:EXE (11/28/2025, 7:00:00 PM)
20.55
-0.44 (-2.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners27.27%
Inst Owner ChangeN/A
Ins Owners13.13%
Ins Owner ChangeN/A
Market Cap1.72B
Revenue(TTM)1.59B
Net Income(TTM)91.00M
Analysts75
Price Target19 (-7.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.4% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP45.22%
Div Incr Years1
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.79%
PT rev (3m)14.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.96%
EPS NY rev (3m)-0.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.87%
Revenue NY rev (3m)0.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.76 | ||
| Fwd PE | 21.11 | ||
| P/S | 1.08 | ||
| P/FCF | 17.28 | ||
| P/OCF | 11.27 | ||
| P/B | 10.51 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.42 |
EPS(TTM)1.04
EY5.06%
EPS(NY)0.97
Fwd EY4.74%
FCF(TTM)1.19
FCFY5.79%
OCF(TTM)1.82
OCFY8.87%
SpS18.97
BVpS1.96
TBVpS-0.41
PEG (NY)0.83
PEG (5Y)0.87
Graham Number6.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROCE | 24.53% | ||
| ROIC | 18.54% | ||
| ROICexc | 26.92% | ||
| ROICexgc | 58.63% | ||
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% | ||
| FCFM | 6.27% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexgc growth 3Y72.34%
ROICexgc growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Debt/EBITDA | 1.91 | ||
| Cap/Depr | 150.97% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | 9.89 | ||
| Cash Conversion | 92.12% | ||
| Profit Quality | 109.55% | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 3.18 |
F-Score6
WACC7.68%
ROIC/WACC2.41
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
EPS Next Y23.8%
EPS Next 2Y10.47%
EPS Next 3Y5.59%
EPS Next 5Y9.75%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
Revenue Next Year12.04%
Revenue Next 2Y9.4%
Revenue Next 3Y6.78%
Revenue Next 5Y10.83%
EBIT growth 1Y30.7%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year-0.49%
EBIT Next 3Y2.81%
EBIT Next 5Y9.15%
FCF growth 1Y199.78%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y343.54%
OCF growth 3Y31.32%
OCF growth 5Y26.02%
EXTENDICARE INC / EXE.CA FAQ
What is the fundamental rating for EXE stock?
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.
Can you provide the valuation status for EXTENDICARE INC?
ChartMill assigns a valuation rating of 6 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.
What is the profitability of EXE stock?
EXTENDICARE INC (EXE.CA) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for EXE stock?
The Price/Earnings (PE) ratio for EXTENDICARE INC (EXE.CA) is 19.76 and the Price/Book (PB) ratio is 10.51.
What is the financial health of EXTENDICARE INC (EXE.CA) stock?
The financial health rating of EXTENDICARE INC (EXE.CA) is 5 / 10.